Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-015605·Atara Biotherapeutics, Inc.
Schedule 13G ownership disclosure
Atara Biotherapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 046513206
Event date: 2025-01-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Panacea Venture Healthcare Fund II, L.P.
Shares: 550,000 · Class: 9.5%
- Panacea Venture Healthcare Fund II GP Company, Ltd.
Shares: 550,000 · Class: 9.5%
- Panacea Innovation Limited
Shares: 550,000 · Class: 9.5%
- James Huang
Shares: 550,000 · Class: 9.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-015605
- Form type
- SCHEDULE 13G
- Filer
- Atara Biotherapeutics, Inc.
- CIK
- CIK 1604464
- Filed
- Feb 06, 2025
- Reporting period
- Jan 30, 2025
- Description
- Schedule 13G beneficial ownership